ZA86997B - Dihydropyridine alkanol amines,process for their preparation and pharmaceutical compositions containing them - Google Patents

Dihydropyridine alkanol amines,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA86997B
ZA86997B ZA86997A ZA86997A ZA86997B ZA 86997 B ZA86997 B ZA 86997B ZA 86997 A ZA86997 A ZA 86997A ZA 86997 A ZA86997 A ZA 86997A ZA 86997 B ZA86997 B ZA 86997B
Authority
ZA
South Africa
Prior art keywords
dihydropyridine
preparation
pharmaceutical compositions
compositions containing
alkanol amines
Prior art date
Application number
ZA86997A
Inventor
Rodney Brian Hargreaves
Bernard Joseph Mcloughlin
Stuart Dennett Mills
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA86997B publication Critical patent/ZA86997B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA86997A 1985-02-11 1986-02-11 Dihydropyridine alkanol amines,process for their preparation and pharmaceutical compositions containing them ZA86997B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503424A GB8503424D0 (en) 1985-02-11 1985-02-11 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ZA86997B true ZA86997B (en) 1986-12-30

Family

ID=10574269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA86997A ZA86997B (en) 1985-02-11 1986-02-11 Dihydropyridine alkanol amines,process for their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0194750A1 (en)
JP (1) JPS61246162A (en)
AU (2) AU5397486A (en)
DK (1) DK66086A (en)
ES (1) ES8802026A1 (en)
FI (1) FI860622A (en)
GB (1) GB8503424D0 (en)
GR (1) GR860382B (en)
HU (1) HUT40416A (en)
IL (1) IL77849A0 (en)
NO (1) NO860471L (en)
PT (1) PT82021B (en)
WO (1) WO1986004581A1 (en)
ZA (1) ZA86997B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
EP0254682A1 (en) * 1986-07-22 1988-01-27 Ciba-Geigy Ag Phenoxyaliphatylphenylenoxyalkylesters and -amides
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
EP0352863A3 (en) * 1988-07-29 1990-08-22 ZAMBON GROUP S.p.A. 1,4-dihydropyridine dicarboxylic acid derivatives
US5468746A (en) * 1988-07-29 1995-11-21 Zambon Group S.P.A. Compounds active on the cardiovascular system
IT1229118B (en) * 1988-07-29 1991-07-22 Simes ACTIVE COMPOUNDS ON THE CARDIOVASCULAR SYSTEM THAT PRESENT BOTH THE STRUCTURE OF BETA-LOCKERS AND A FOOTBALL-ANTAGONIST PORTION
CA2350854C (en) * 1990-11-30 2005-01-04 Ucb Japan Co., Ltd. 1,4-dihydropyridine derivatives and methods of producing the same
DE4131346A1 (en) * 1991-09-20 1993-03-25 Bayer Ag INDOLSULFONAMIDE SUBSTITUTED DIHYDROPYRIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
WO1994002463A1 (en) * 1992-07-28 1994-02-03 Fujisawa Pharmaceutical Co., Ltd. Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation
NL1012886C1 (en) 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carboxylic acid ester derivatives and process for their preparation.
JP2008521805A (en) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス, インコーポレイテッド Cardiotonic compounds having inhibitory activity against β-adrenergic receptors and phosphodiesterases
CN101215258A (en) * 2008-01-21 2008-07-09 中国药科大学 Dihydropyridines calcium antagonist compounds, preparation method and medical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
JPS60156671A (en) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd Dihydropyridine derivative and its preparation

Also Published As

Publication number Publication date
NO860471L (en) 1986-08-12
IL77849A0 (en) 1986-08-31
HUT40416A (en) 1986-12-28
PT82021A (en) 1986-03-01
GB8503424D0 (en) 1985-03-13
DK66086D0 (en) 1986-02-11
FI860622A0 (en) 1986-02-11
ES551843A0 (en) 1988-03-16
ES8802026A1 (en) 1988-03-16
WO1986004581A1 (en) 1986-08-14
AU5339386A (en) 1986-08-14
DK66086A (en) 1986-08-12
PT82021B (en) 1987-12-16
JPS61246162A (en) 1986-11-01
AU5397486A (en) 1986-08-26
GR860382B (en) 1986-05-29
EP0194750A1 (en) 1986-09-17
FI860622A (en) 1986-08-12

Similar Documents

Publication Publication Date Title
DE3666036D1 (en) Phenylethanol aminotetralines, process for their preparation and pharmaceutical compositions containing them
IL79572A0 (en) 2-thiomethyl-substituted-1,4-dihydropyridines,method for their preparation and pharmaceutical compositions containing them
EP0236624A3 (en) Substituted phenyl ethanol amines, processes for their preparation and pharmaceutical compositions containing them
IL84863A (en) 3-aryloxy-3-substituted propanamines,process for their preparation and pharmaceutical compositions comprising them
IL78569A (en) Substituted carboxamido-benz-heterocyclyl-methyl-benzoic acids,process for their preparation and pharmaceutical compositions comprising them
DE3461090D1 (en) 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
HUT40453A (en) Process for producing 11-beta-phenyl-gonanes and pharmaceutical compositions containing them
HUT41772A (en) Process for producing /4-substituted-piperazinyl- and -homopiperazinyl/-pyridazines and pharmaceutical compositions containing them
IL85247A (en) Polyamine derivatives,process for their preparation and pharmaceutical compositions containing them
IL85996A0 (en) Tertiary arylethyl amine derivatives,their preparation and pharmaceutical compositions containing them
ZA86997B (en) Dihydropyridine alkanol amines,process for their preparation and pharmaceutical compositions containing them
EP0145121A3 (en) Pyrazoloquinolines, process for their preparation, and pharmaceutical compositions containing them
GR3001416T3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
IL80394A0 (en) Antihypertensive thieno-isoxazoles and thieno-pyrazoles,process for their preparation and pharmaceutical compositions containing them
EP0172004A3 (en) Quinolinones, process for their preparation and pharmaceutical compositions containing them
GR862030B (en) Method for preparing pharmaceutical compositions
IL80835A (en) N-(pyrrol-1-yl)pyridine amines,process for their preparation and pharmaceutical compositions containing them
PT82960A (en) Process for preparing 5-substituted-6-amino-pyrimidine derivatives and pharmaceutical compositions containing them
HUT41762A (en) Process for producing thieno-benzo-pyranes, -thiopyranes and naphtothiophenes and pharmaceutical compositions containing them
IL77843A (en) Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
IL76335A0 (en) Tertiary amine derivatives,their preparation and pharmaceutical compositions containing them
GB2138817B (en) 4-pheny-tetrahydro-furano-pyridines, process for their preparation, and pharmaceutical compositions containing them
DE3380875D1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them
ZA837081B (en) Piperidine derivatives,processes for their preparation and pharmaceutical compositions containing them